Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion type Assertion NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_head.
- NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion description "[At least three mechanisms are thought to contribute to the metastasis-suppressive effect of Nm23-H1: (a) its histidine kinase activity toward ATP-citrate lyase, aldolase C, and the kinase suppressor of ras, with the last inactivating mitogen-activated protein kinase signaling; (b) binding proteins that titer out `free` Nm23-H1 and inhibit its ability to suppress metastasis; and (c) altered gene expression downstream of Nm23-H1, particularly an inverse association with the lysophosphatidic acid receptor endothelial differentiation gene-28 (EDG2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_provenance.
- NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion evidence source_evidence_literature NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_provenance.
- NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion SIO_000772 18698018 NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_provenance.
- NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion wasDerivedFrom befree-20140225 NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_provenance.
- NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_assertion wasGeneratedBy ECO_0000203 NP418441.RAB0eJnx8V8jdtavocZyY8e5allYNy3FQqS9HTCtpXy9Y130_provenance.